Keywords: Lundbeck, Proximagen, Equity stake, CNS research partnership

Lundbeck partners with Proximagen, buying around a 9%equity stake in the firm

Article | 30 September 2011

Print This

Danish central nervous system specialist Lundbeck (LUND: DC) and the UK’s Proximagen Group (AIM: PRX), have entered into ...

Enjoying this article? To continue reading you need to login or subscribe.

Subscribe now
for unlimited access to all articles

Subscriptions are £60 per month, pay as you go.
Find out more details.

Already a subscriber? Click here to log in